Global RNA Gene Expression Sequencing Market Growth (Status and Outlook) 2024-2030

Global RNA Gene Expression Sequencing Market Growth (Status and Outlook) 2024-2030

RNA gene expression sequencing is a high-throughput sequencing technology used to analyze the type and amount of RNA in cells or tissues to understand the expression patterns and levels of genes. Through RNA gene expression sequencing, comprehensive quantitative analysis of the transcriptome can be performed, including identifying the type and number of transcripts, detecting gene expression levels, and discovering new RNA species. This technology is of great significance for studying gene expression regulation, diagnosing diseases and discovering new drug targets.

The global RNA Gene Expression Sequencing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “RNA Gene Expression Sequencing Industry Forecast” looks at past sales and reviews total world RNA Gene Expression Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected RNA Gene Expression Sequencing sales for 2023 through 2029. With RNA Gene Expression Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA Gene Expression Sequencing industry.

This Insight Report provides a comprehensive analysis of the global RNA Gene Expression Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on RNA Gene Expression Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNA Gene Expression Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA Gene Expression Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA Gene Expression Sequencing.

United States market for RNA Gene Expression Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for RNA Gene Expression Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for RNA Gene Expression Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key RNA Gene Expression Sequencing players cover Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of RNA Gene Expression Sequencing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Total RNA
Noncoding RNA

Segmentation by Application:
Biomedical Field
Non-medical Field

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Total RNA
Noncoding RNA

Segmentation by Application:
Biomedical Field
Non-medical Field

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang Biology
Novogene Co., Ltd
Macrogen
Tsingke Biotechnology Co., Ltd.

Please note: The report will take approximately 2 business days to prepare and deliver.